α-Conotoxin MI is a small, disulfide-rich conopeptide that targets nicotinic acetylcholine receptors in biochemical models. Two disulfide bonds lock its loops into a compact, well-defined architecture. Researchers map receptor subtype selectivity using electrophysiology and structural techniques. Applications include ion-channel pharmacology, neurotoxin motif characterization, and cystine-knot peptide engineering.
α-Conotoxin MI is a well-characterized peptide toxin derived from the venom of the marine cone snail *Conus magus*. As a member of the α-conotoxin family, it is composed of a short sequence of amino acids forming a distinctive disulfide-bonded structure that confers high selectivity for nicotinic acetylcholine receptors (nAChRs), particularly the muscle-type subtypes. Its ability to target and modulate ligand-gated ion channels has made it a valuable molecular tool in neuropharmacology, receptor biology, and peptide structure-function studies. The unique specificity and potent activity of this conotoxin have positioned it as a critical reagent for dissecting cholinergic signaling pathways and advancing the understanding of synaptic transmission.
Neuroreceptor characterization: α-Conotoxin MI is widely employed in the functional characterization of nicotinic acetylcholine receptors, especially in the context of muscle-type nAChRs. By selectively binding to the α1β1γδ receptor subtype, it enables researchers to distinguish between receptor isoforms and to map the pharmacological profiles of various cholinergic synapses. This selectivity aids in elucidating the structural determinants of receptor-ligand interactions, supporting the development of new molecular probes and advancing the fundamental knowledge of ion channel pharmacology.
Ion channel modulation studies: The peptide serves as a precise molecular probe for investigating the mechanisms of ion channel gating and inhibition. Its rapid and reversible blockade of nAChRs allows for real-time analysis of channel kinetics, desensitization processes, and the conformational dynamics underlying receptor function. Such studies provide critical insights into the allosteric modulation of ligand-gated ion channels and inform the rational design of synthetic analogs with tailored pharmacological properties.
Peptide structure-activity relationship (SAR) analysis: Due to its compact and structurally constrained framework, α-Conotoxin MI is frequently utilized in structure-activity relationship studies to explore how specific amino acid substitutions or modifications impact receptor selectivity and potency. Researchers leverage this peptide as a scaffold for generating analogs and for mapping the functional contributions of individual residues, thereby informing the design of next-generation peptide ligands with enhanced selectivity or stability.
Tool for synaptic transmission research: In neurobiological research, α-Conotoxin MI is an essential tool for dissecting the roles of muscle-type nAChRs in synaptic transmission. By selectively inhibiting postsynaptic cholinergic signaling, it allows for the isolation and analysis of presynaptic versus postsynaptic contributions to neuromuscular communication. This application is particularly valuable in studies aiming to understand synaptic plasticity, neurotransmitter release dynamics, and the molecular underpinnings of neuromuscular disorders.
Analytical assay development: The high specificity and well-defined activity profile of α-Conotoxin MI make it suitable for use in the development of receptor-binding assays and analytical platforms. It is often incorporated into ligand-binding studies, high-throughput screening systems, and competitive binding assays designed to quantify receptor expression or to identify novel modulators of nAChRs. Such applications facilitate the discovery of new pharmacological agents and support the validation of receptor-targeted screening methodologies in both academic and industrial research settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More